HEK293 3D Suspension Cell Harvesting Protocol | Enzyme-Free

This section explains why 3D cell culture is superior to traditional 2D monolayer cultures. Standard 2D cultures inadequately represent the in vivo environment, making them unreliable predictors of drug efficacy and toxicity. In 3D cultures, cells grow in all directions with natural cell-cell and cell-matrix interactions occurring. 3D systems develop natural gradients for nutrients, oxygen, pH, and other factors, whereas 2D systems lack these gradients entirely. 3D tumor spheroids replicate in vivo tumor architecture with peripheral proliferative cells, intermediate layers, and necrotic cores, mimicking oxygen and nutrient diffusion patterns. Living tissues contain stromal cells (fibroblasts, adipocytes, glial cells, endothelial cells, immune cells) that interact with epithelial and neuronal tissues, regulating disease progression and therapeutic responses. These complex 3D environments enable more accurate modeling of cellular behavior and responses to treatments.

3D spheroid cultures offer significant advantages over 2D systems including: (1) Higher physiological function - spheroids achieve nearly double albumin secretion and substantially increased phase I/II enzyme activity compared to 2D; (2) Extended longevity - enabling 10-30 day cultures versus 5-7 days for 2D, allowing long-term studies like fibrosis modeling, inflammation studies, and disease progression research; (3) Applications for implantable tissues - spheroids can be encapsulated in alginate or printed for therapeutic applications; (4) Better prediction of idiosyncratic toxicity - 3D systems better model complex cellular interactions involving Kupffer cells and stellate cells that contribute to unpredictable drug reactions.

Drug effects on cancer cells differ significantly between 2D monolayer and 3D spheroid culture systems. In 2D conditions, 5-fluorouracil reduced complement-dependent cytotoxicity induced by cetuximab. However, in 3D spheroid conditions, the same treatment increased cytotoxicity. This difference may be explained by tumor microenvironment structure affecting drug penetration and cell-cell interactions. Spheroid culture conditions themselves can induce phenotypic plasticity, causing non-stem cells to acquire stem cell characteristics. Cell proliferation analysis revealed that drug effects on proliferation versus sphere formation are concentration-dependent, with higher concentrations inhibiting proliferation while lower concentrations maintain proliferative capacity.

Cell cultures are classified by tissue origin (epithelial, osteosarcoma, etc.) and growth format (adherent or suspension). Traditional 2D monolayer cultures are easier to use and process but lack physiological accuracy. 3D culture systems better mimic in vivo conditions by incorporating extracellular matrix components. Three major 3D methods exist: scaffold-based cultures, aggregate cultures, and microcarrier systems. Microgravity conditions further enhance physiological relevance by reducing mechanical stress between cells and their environment.

Cell culture technology has evolved from 2D monolayer to 3D spheroid systems. In 2D culture, cells grow as flat layers on plastic substrates (Petri dishes or flasks), unable to mimic in vivo microenvironment or cell-to-cell interactions. Cells may lose natural morphology. 2D culture is economical, easy to perform, and has high throughput capacity, making it ideal for large-scale drug screening. In contrast, 3D culture uses natural extracellular matrix, creating spherical aggregates that resemble original tissue. The 3D spatial arrangement affects cell surface receptor organization, proliferation, differentiation, signaling, and gene expression. While 3D culture is expensive and laborious with low throughput, it is essential for tissue engineering and regenerative medicine where physiological relevance is critical.

VitroGel® is a xeno-free, synthetic hydrogel designed for 3D cell culture that offers advantages over traditional animal-based extracellular matrix materials, including room temperature stability, batch-to-batch consistency, and injectable properties with shear-thinning behavior that enables easy handling and application in various research settings from bench to bedside.

Synthetic hydrogel systems like VitroGel offer a well-defined, animal-free alternative to traditional animal-based extracellular matrix (ECM) for xenograft PDX and CDX models, providing consistent mechanical properties, biocompatibility, and the ability to control growth factors and supplements, while maintaining similar tumor growth characteristics compared to animal-based ECM across various cancer cell lines.

The extracellular matrix (ECM) is a three-dimensional scaffold surrounding cells, providing biophysical and biochemical support. Cells constantly remodel the ECM through building, shaping, and reassembling it, and disruptions in these mechanisms cause diseases like fibrosis. Hydrogels—water-swelling polymer networks—have evolved to mimic ECM properties for studying cell behavior. Early breakthroughs showed cells respond to mechanical signals like elasticity, leading to more sophisticated designs incorporating viscoelasticity. However, a fundamental challenge emerged: cells rapidly secrete their own ECM proteins upon encapsulation, forming a nascent matrix that displaces the engineered hydrogel, limiting long-term control over cellular behavior.

A novel preclinical model of normal human breast tissue using VitroGel hydrogel maintains epithelial proliferation, hormone receptor expression (estrogen and progesterone), and immune cell residency (T cells and macrophages) over 7 days without the hyper-proliferation, loss of hormone signaling, or short treatment windows that limit other organotypic tissue culture systems, enabling more accurate testing of breast cancer preventative agents.

The VitroGel® hydrogel system enables researchers to coat cell culture surfaces with varying stiffness and texture, which influences cell behavior including migration and invasion patterns; this 2D coating method supports long-term cell culture as media can penetrate the hydrogel matrix to provide nutrients while allowing easy microscopic observation of cell growth.

Trypsin is an enzyme that breaks down proteins holding cells to culture surfaces. When added to cells, trypsin causes them to detach and become suspended in liquid. The solution becomes cloudy as cells release from the dish. After trypsinization, cells are collected by centrifugation, which pellets them at the bottom of tubes for further processing or analysis.

Trypsin is an endopeptidase that cleaves peptide bonds at the carboxyl side of arginine and lysine. Key limitations include: cannot cleave at terminal positions (first or last amino acid), cannot cleave when proline follows the target residue (due to cis-peptide bond recognition), and cannot cleave at N-terminal positions where trypsin would need to act. These restrictions are essential for understanding why certain sequences remain intact during digestion.

Enzymatic disaggregation uses enzymes to dissolve collagen between cells gently. Trypsin is used for moderate cells, while collagenase is preferred for sensitive cells that would be damaged by trypsin. The trypsinization process is classified as cold (ice-cold trypsin, 1-6 hours soaking) or warm (37°C trypsin, 3-4 hours with continuous magnetic stirring). After disaggregation, centrifugation separates live cells (which settle) from dead cells and debris (which float). The live cell pellet is collected for inoculation into appropriate culture media.

Trypsinization is the enzymatic process used to detach adherent cells from culture flasks for passaging. Cells are either adherent (attach to flask surface) or suspension (grow freely). Trypsin, a serine protease, breaks down proteins anchoring cells to the surface. The process requires PBS, trypsin-EDTA solution, complete medium, sterile pipettes, CO2 incubator, and inverted microscope. All materials must be pre-warmed to 37°C to ensure optimal enzyme activity and prevent thermal shock. The old culture medium is removed under biosafety cabinet conditions to prevent contamination.

Adherent cells must be passaged before reaching 80% confluence to maintain optimal growth. Trypsin/EDTA solution is used to detach cells by breaking protein-protein connections. Trypsin is a serine protease that cuts various proteins, while EDTA acts as a chelator that removes calcium ions, weakening calcium-dependent adhesion proteins like cadherins. This combination effectively releases cells from the culture surface and from each other.